Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the LillyMedical.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to LillyMedical.com.

  1. Medical Information Right
  2. Immunology Right
  3. Taltz (ixekizumab) injection Right
  4. What information is available on Taltz® (ixekizumab) delivery devices and administration?
Search Taltz (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Taltz ® (ixekizumab) injection

80 mg/mL

Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

What information is available on Taltz® (ixekizumab) delivery devices and administration?

Ixekizumab is available both as an autoinjector and prefilled syringe for subcutaneous administration.

US_cFAQ_IXE307_DELIVERY_DEVICES_ADMINISTRATION
US_cFAQ_IXE307_DELIVERY_DEVICES_ADMINISTRATION
en-US

Delivery Devices

Ixekizumab is available both as an autoinjector and prefilled syringe for subcutaneous (SC) administration.1

Ixekizumab is intended for use under the guidance and supervision of a physician. Patients may self-inject after training in SC injection technique using the autoinjector or prefilled syringe.1

Administration

Each ixekizumab injection is to be administered

  • at a different anatomic location (such as upper arms, thighs, or any quadrant of the abdomen) than the previous injection, and
  • not into areas where the skin is tender, bruised, erythematous, indurated, or affected by psoriasis.1

Administration into the upper outer arm may be performed by a caregiver or healthcare provider.1

Preparation and Use

Before injection, remove the autoinjector or prefilled syringe from the refrigerator and allow ixekizumab to reach room temperature (30 minutes) without removing the needle cap.1

Inspect ixekizumab visually for particulate matter and discoloration prior to administration. The ixekizumab solution should appear clear and colorless to slightly yellow. Do not use if the liquid contains visible particles, is discolored or cloudy (other than clear and colorless to slightly yellow).1

Ixekizumab does not contain preservatives, therefore discard any unused product remaining in the autoinjector or prefilled syringe.1

Instruct patients using the autoinjector or prefilled syringe to inject the full amount (1 mL), which provides 80 mg of ixekizumab, according to the directions provided in the instructions for use.

Each autoinjector and prefilled syringe contain a single-dose (80 mg/mL) solution of ixekizumab.1

Enclosed Prescribing Information

TALTZ® (ixekizumab) injection, for subcutaneous administration, Lilly

References

1Taltz [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.

Date of Last Review: April 27, 2022

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.17 02/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    facebook twitter linkedin
    visit www.phactmi.org
    Lilly